Histone Deacetylase Inhibitors: a Chemical Genetics Approach to Understanding Cellular Functions

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2010 Jul 3

PMID 20594930

Citations 75

Authors

Paul A Marks

Affiliations

Soon will be listed here.

Abstract

There are eleven zinc dependent histone deacetylases (HDAC) in humans which have histones and many non-histone substrates. The substrates of these enzymes include proteins that have a role in regulation of gene expression, cell proliferation, cell migration, cell death, immune pathways and angiogenesis. Inhibitors of HDACs (HDACi) have been developed which alter the structure and function of these proteins, causing molecular and cellular changes that induce transformed cell death. The HDACi are being developed as anti-cancer drugs and have therapeutic potential for many non-oncologic diseases.

Citing Articles

Modulation of biological activities in adipose derived stem cells by histone deacetylation.

Abdallah S, Tabebi M, Qanadilo S, Ali N, Wang J, Darcy P Sci Rep. 2025; 15(1):3629.

PMID: 39880862 PMC: 11779964. DOI: 10.1038/s41598-024-84652-1.

Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier.

Sadanandan J, Thomas S, Mathew I, Huang Z, Blackburn S, Tandon N Elife. 2024; 12.

PMID: 39670988 PMC: 11643625. DOI: 10.7554/eLife.86978.

Effect of valproic acid on histone deacetylase expression in oral cancer (Review).

Al-Khafaji A, Wang L, Alabdei H, Liloglou T Oncol Lett. 2024; 27(5):197.

PMID: 38516679 PMC: 10955681. DOI: 10.3892/ol.2024.14330.

The Effects of Green Tea Catechins in Hematological Malignancies.

Della Via F, Alvarez M, Basting R, Olalla Saad S Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513933 PMC: 10385775. DOI: 10.3390/ph16071021.

Class I HDAC inhibitors attenuate dexamethasone-induced muscle atrophy via increased protein kinase C (PKC) delta phosphorylation.

Habibian J, Bolino M, Qian A, Woolsey R, Quilici D, Petereit J Cell Signal. 2023; 110:110815.

PMID: 37478958 PMC: 10528066. DOI: 10.1016/j.cellsig.2023.110815.

References

Liu L, Chang H, Chiang L, Hung W . Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res. 2003; 63(12):3069-72. View

Marks P, Breslow R . Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007; 25(1):84-90. DOI: 10.1038/nbt1272. View

Richon V, Garcia-Vargas J, Hardwick J . Development of vorinostat: current applications and future perspectives for cancer therapy. Cancer Lett. 2009; 280(2):201-10. DOI: 10.1016/j.canlet.2009.01.002. View

Chen B, Cepko C . HDAC4 regulates neuronal survival in normal and diseased retinas. Science. 2009; 323(5911):256-9. PMC: 3339762. DOI: 10.1126/science.1166226. View

Kelly W, Marks P . Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol. 2005; 2(3):150-7. DOI: 10.1038/ncponc0106. View

Marks P, Xu W . Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem. 2009; 107(4):600-8. PMC: 2766855. DOI: 10.1002/jcb.22185. View

Hockly E, Richon V, Woodman B, Smith D, Zhou X, Rosa E . Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A. 2003; 100(4):2041-6. PMC: 149955. DOI: 10.1073/pnas.0437870100. View

Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F . Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem. 2005; 280(29):26729-34. DOI: 10.1074/jbc.C500186200. View

Adcock I . HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol. 2007; 150(7):829-31. PMC: 2013887. DOI: 10.1038/sj.bjp.0707166. View

10.

Mai A, Rotili D, Valente S, Kazantsev A . Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise. Curr Pharm Des. 2009; 15(34):3940-57. DOI: 10.2174/138161209789649349. View

11.

Romagnani P, Lasagni L, Mazzinghi B, Lazzeri E, Romagnani S . Pharmacological modulation of stem cell function. Curr Med Chem. 2007; 14(10):1129-39. DOI: 10.2174/092986707780362880. View

12.

Chang H, Chiang C, Hung H, Lin C, Deng Y, Yen-Ping Kuo M . Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol. 2008; 45(7):610-4. DOI: 10.1016/j.oraloncology.2008.08.011. View

13.

Ayton P, Cleary M . Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001; 20(40):5695-707. DOI: 10.1038/sj.onc.1204639. View

14.

Xu W, Perez G, Ngo L, Gui C, Marks P . Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. Cancer Res. 2005; 65(17):7832-9. DOI: 10.1158/0008-5472.CAN-04-4608. View

15.

Ma X, Ezzeldin H, Diasio R . Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs. 2009; 69(14):1911-34. DOI: 10.2165/11315680-000000000-00000. View

16.

Parmigiani R, Xu W, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P . HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci U S A. 2008; 105(28):9633-8. PMC: 2443817. DOI: 10.1073/pnas.0803749105. View

17.

Jenuwein T, Allis C . Translating the histone code. Science. 2001; 293(5532):1074-80. DOI: 10.1126/science.1063127. View

18.

Taddei A, Maison C, Roche D, Almouzni G . Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol. 2001; 3(2):114-20. DOI: 10.1038/35055010. View

19.

Coffey D, Kutko M, Glick R, Butler L, Heller G, Rifkind R . The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res. 2001; 61(9):3591-4. View

20.

Joseph J, Mudduluru G, Antony S, Vashistha S, Ajitkumar P, Somasundaram K . Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene. 2004; 23(37):6304-15. DOI: 10.1038/sj.onc.1207852. View